Nunurai Ruswa

Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort

Evans Sagwa, Nunurai Ruswa, Farai Mavhunga et al. · BMC Pharmacology and Toxicology · 2015 · 72 citations · Full text

Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes

Leonardo de Araujo, Andrea Maurizio Cabibbe, Lusia Mhuulu et al. · Frontiers in Public Health · 2023 · 43 citations · Full text

The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia.

Evans Sagwa, Aukje K. Mantel‐Teeuwisse, Nunurai Ruswa et al. · PubMed · 2012 · 29 citations · Full text

Adverse Events During Treatment of Drug-Resistant Tuberculosis: A Comparison Between Patients With or Without Human Immunodeficiency Virus Co-infection

Evans Sagwa, Nunurai Ruswa, Jean Paul Musasa et al. · Drug Safety · 2013 · 28 citations

Adverse Events, Pulmonary Tuberculosis, Treatment And Prevention +9

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

Evans Sagwa, Aukje K. Mantel‐Teeuwisse, Nunurai Ruswa · Journal of Pharmaceutical Policy and Practice · 2014 · 25 citations · Full text